New research indicates that individuals who come off blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who halt conventional diet and exercise regimens.
Research printed in a major health publication points out that while obese individuals often shed about a fifth of their body weight while using the jabs, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"Users buying such treatments must be cognizant of the risk of rapid weight regain when the therapy concludes," warns researcher Dr. Susan Jebb.
This pace of recovery implies a return to original mass in about 18 months.
Analyzing Therapies
The research, which reviewed dozens of studies involving thousands of participants, compared the effects of these new drugs with other pills.
The team note that individuals who shed pounds through diet and exercise typically see a less rapid creep back—around 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Nutrition scientists suggest the way of the jabs is key to understanding the accelerated regain.
The injections mimic a natural hormone called GLP-1, which moderates appetite.
"Artificially providing the hormone concentrations several times higher than normal could lead to the body to produce less of its endogenous GLP-1, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication results in hunger is no longer kept in check, making overeating far more likely."
A Chronic Disease?
Health authorities recommend the jabs for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts contend that, due to the high risk of relapse, the treatment might need to be long-term.
This opinion is reinforced by drug manufacturers, who state that the results "emphasize the long-term character of obesity," similar to managing diseases like diabetes.
User Accounts
Users who have come off the jabs describe a intense resurgence of cravings.
"I experienced a trigger activating and you become extremely hungry," recalled an individual.
This difficulty is worsened if individuals have not established permanent lifestyle or habit modifications during treatment.
Significant Adoption
Figures indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.
- Adoption is greater among women than men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Ultimately, researchers stress that while the jabs are effective agents for shedding pounds, they are not a magic solution and maintained weight loss relies on integrated behavioural changes.
